Alıntılar

APA (7. basım) Alıntı
Hall, A., Brown, S., Hinsley, S., Sherratt, D., Flanagan, L., Roberts, S., . . . Kaiser, M. (2021). MUKnine OPTIMUM protocol: A screening study to identify high-risk patients with multiple myeloma suitable for novel treatment approaches combined with a phase II study evaluating optimised combination of biological therapy in newly diagnosed high-risk multiple myeloma and plasma cell leukaemia. BMJ Publishing Group.
Chicago Style (17. basım) Atıf
Hall, Andrew, et al. MUKnine OPTIMUM Protocol: A Screening Study to Identify High-risk Patients with Multiple Myeloma Suitable for Novel Treatment Approaches Combined with a Phase II Study Evaluating Optimised Combination of Biological Therapy in Newly Diagnosed High-risk Multiple Myeloma and Plasma Cell Leukaemia. BMJ Publishing Group, 2021.
MLA (9th ed.) Atıf
Hall, Andrew, et al. MUKnine OPTIMUM Protocol: A Screening Study to Identify High-risk Patients with Multiple Myeloma Suitable for Novel Treatment Approaches Combined with a Phase II Study Evaluating Optimised Combination of Biological Therapy in Newly Diagnosed High-risk Multiple Myeloma and Plasma Cell Leukaemia. BMJ Publishing Group, 2021.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..